Document:

Filed by Automated Filing Services Inc. (604) 609-0244 - ImVisioN Therapeutics Inc. - Exhibit 4.1

EXHIBIT 4.1

SUBSCRIPTION AGREEMENT

THIS AGREEMENT is made effective as of the ______ day of
_________________, 2006.

BETWEEN:

THE SUBSCRIBER NAMED ON THE
EXECUTION PAGE 
TO THIS AGREEMENT

(hereinafter called the
"Subscriber")

OF THE FIRST PART

AND:

IMVISION THERAPEUTICS
INC., 
a Nevada corporation

(hereinafter called the “Company")

OF THE SECOND PART

NOW THEREFORE, in consideration of the premises and the
mutual covenants contained herein and other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the parties agree as
follows: 

1.                        
Definitions

1.1                     
The following terms will have the following meanings for all purposes of this
Agreement.

	 	(a) 	
      "Agreement" shall mean this Agreement, and all schedules
      and amendments to in the Agreement.

	 	 	 
	 	(b) 	
      “Common Stock” means the shares of common stock of the
      Company, $0.001 par value per share.

	 	 	 
	 	(c) 	
      "Exchange Act" shall mean the United States Securities
      Exchange Act of 1934, as amended.

	 	 	 
	 	(d) 	
      "Offering" shall mean the offering of up 10,000,000
      shares of Common Stock by the Company at a price of $0.75 per
  share.

	 	 	 
	 	(e) 	
      “Prospectus” means the prospectus forming a part of the
      Registration Statement, as amended and supplemented from time to time in
      accordance with the rules and requirements of the Securities
Act.

	 	 	 
	 	(f) 	
      “Purchase Price” means the purchase price payable by the
      Subscriber to the Company in consideration for the purchase and sale of
      the Shares in accordance with Section 2.1 of this
  Agreement.

2

	 	(g) 	
      “Registration Statement” means the registration statement
      on Form SB-2 filed by the Company with the SEC pursuant to the Securities
      Act, as amended.

	 	 	 
	 	(h) 	
      "SEC" shall mean the United States Securities and
      Exchange Commission.

	 	 	 
	 	(i) 	
      "Securities Act" shall mean the United States Securities
      Act of 1933, as amended.

	 	 	 
	 	(j) 	
      "Shares" means those shares of Common Stock to be
      purchased by the Subscriber.

	 	 	 
	 	(k) 	
      “Subscriber” shall mean the Subscriber executing the
      signature page to this Agreement.

1.2                      
All dollar amounts referred to in this agreement are in United States funds,
unless expressly stated otherwise.

2.                        
Purchase and Sale of Shares

2.1                      
Subject to the terms and conditions of this Agreement, the Subscriber hereby
subscribes for and agrees to purchase from the Company such number of Shares as
is set forth upon the signature page hereof at a price equal to $0.75 US per
Share. Upon execution, the subscription by the Subscriber will be
irrevocable.

2.2                      
The Subscriber will complete the purchase of the Shares by delivering to the
Company payment of the Purchase Price concurrently with the execution and
delivery of this Subscription Agreement by (i) cheque, bank draft on cashier’s
cheque payable to the Company, or (ii) wiring funds to the bank of account of
the Company in accordance with wire transfer instructions provided by the
Company to the Subscriber.

2.3                      
Upon execution by the Company, the Company agrees to sell such Shares to the
Subscriber for the Purchase Price subject to the Company's right to sell to the
Subscriber such lesser number of Shares as it may, in its sole discretion, deem
necessary or desirable.

2.4                      
Any acceptance by the Company of the Subscription is conditional upon compliance
with all securities laws and other applicable laws of the jurisdiction in which
the Subscriber is resident. Each Subscriber will deliver to the Company all
other documentation, agreements, representations and requisite government forms
required by the lawyers for the Company as required to comply with all
securities laws and other applicable laws of the jurisdiction of the
Subscriber.

2.5                      
Pending acceptance of this subscription by the Company, all funds paid by the
Subscriber shall be deposited by the Company and immediately available to the
Company for its corporate purposes. In the event the subscription is not
accepted, the subscription funds will be returned to the Company as promptly as
possible.

2.6                      
The Subscriber hereby authorizes and directs the Company to deliver the
certificates representing the securities to be issued to such Subscriber
pursuant to this Agreement to the Subscriber’s address indicated on the
signature page of this Agreement.

2.7                      
The Subscriber acknowledges and agrees that the subscription for the Shares and
the Company's acceptance of the subscription is not subject to any minimum
subscription for the Offering.

3

3.                        
Agreements, Representations and Warranties of the
Subscriber

3.1                      
The Subscriber acknowledges and agrees that offer and sale of the Shares has
been registered by the Company under the Securities Act by the filing of the
Registration Statement with the Securities and Exchange Commission.

3.2                      
The Subscriber acknowledges receipt from the Company of a Prospectus prior to
the execution of this Agreement and confirms that the Subscriber has had the
opportunity to review the Prospectus and to discuss the Prospectus and an
investment in the Shares with the Subscriber’s professional advisors prior to
execution of this Agreement.

3.3                      
This Agreement has been duly authorized, validly executed and delivered by the
Subscriber.

3.4                      
The Subscriber has satisfied himself or herself as to the full observance of the
laws of his or her jurisdiction in connection with any invitation to subscribe
for the Shares or any use of this Agreement, including (i) the legal
requirements within his jurisdiction for the purchase of the Shares; (ii) any
foreign exchange restrictions applicable to such purchase; (iii) any
governmental or other consents that may need to be obtained; (iv) the income tax
and other tax consequences, if any, that may be relevant to an investment in the
Shares; and (v) any restrictions on transfer applicable to any disposition of
the Shares imposed by the jurisdiction in which the Subscriber is resident.

4.                       
Representations and Warranties of the Company

4.1                     
The Company represents and warrants to the Subscriber and acknowledges that the
Subscriber is relying upon such representations and warranties in connection
with the execution, delivery and performance of this Agreement:

	 	(a) 	
      The Company is a corporation duly incorporated and in
      good standing under the laws of the State of Nevada, and has the requisite
      corporate power and authority to conduct its business as it is currently
      being conducted, to enter into this Agreement and to sell the Shares to
      the Subscriber.

	 	 	 
	 	(b) 	
      The execution and delivery by the Company of this
      Agreement has been duly authorized by all necessary action on the part of
      the Company, and no further consent or action is required by the Company,
      its board of directors or its stockholders.

	 	 	 
	 	(c) 	
      The issuance of the Shares has been duly authorized by
      all necessary corporate action of the Company.

	 	 	 
	 	(d) 	
      Upon payment of the subscription price and issuance in
      accordance with the terms and conditions of this Agreement, the Shares
      will be validly issued, fully paid and non-assessable shares of the
      Company’s common stock.

	 	 	 
	 	(e) 	
      The existing stockholders of the Company have no
      pre-emptive or similar rights to purchase shares of Common Stock from the
      Company.

	 	 	 
	 	(f) 	
      The issue and sale of the Shares by the Company does not
      and will not conflict with, and does not and will not result in a breach
      of, any of the terms of its

4

Articles of Incorporation or Bylaws or
any agreement or instrument to which the Company is a party.

5.                      
Miscellaneous

5.1                     
Each party is entitled to rely on the representations, warranties and agreements
of each of the other parties and all such representation, warranties and
agreement will be effective regardless of any investigation that any party has
undertaken or failed to undertake. The representation, warranties and agreements
will survive the purchase and sale of the Shares.

5.2                     
Each of the parties hereto will cooperate with the others and execute and
deliver to the other parties hereto such other instruments and documents and
take such other actions as may be reasonably requested from time to time by any
other party hereto as necessary to carry out, evidence, and confirm the intended
purposes of this Agreement.

5.3                     
This Agreement may not be amended except by an instrument in writing signed by
each of the parties.

5.4                     
Each party to this Agreement will bear its respective expenses incurred in
connection with the preparation, execution, and performance of this Agreement
and the transactions contemplated hereby, including all fees and expenses of
agents, representatives, counsel, and accountants. 

5.5                     
This Agreement constitutes the entire agreement between the parties with respect
to the subject matter hereof and supersede all prior arrangements and
understandings, both written and oral, expressed or implied, with respect
thereto. Any preceding correspondence or offers are expressly superseded and
terminated by this Agreement.

5.6                     
If one or more provisions of this Agreement is held to be unenforceable under
applicable law, such provision will be excluded from this Agreement and the
balance of this Agreement will be enforceable in accordance with its terms.

5.7                     
All notices and other communications required or permitted under to this
Agreement must be in writing and will be deemed given if sent by personal
delivery, faxed with electronic confirmation of delivery,
internationally-recognized express courier or registered or certified mail
(return receipt requested), postage prepaid, to the parties at the following
addresses (or at such other address for a party as will be specified by like
notice):

If to the Investor:

at the address set forth on the

signature page to this Agreement

If to the Corporation:

ImVision Therapeutics
Inc.
Feodor-Lynen Str. 5, 30625, Hannover, Germany 
Facsimile:
+49-511-538-896-66 
Attention: Dr. Martin Steiner, Chief Executive
Officer

All such notices and other communications will be deemed to
have been received (a) in the case of personal delivery, on the date of such
delivery, (b) in the case of a fax, when the party sending such fax has received
electronic confirmation of its delivery, (c) in the case of delivery by 

5

internationally-recognized express courier, on the business day
following dispatch and (d) in the case of mailing, on the fifth business day
following mailing.

5.8                     
The headings contained in this Agreement are for convenience purposes only and
will not affect in any way the meaning or interpretation of this Agreement.

5.9                     
This Agreement is and will only be construed as for the benefit of or
enforceable by those persons party to this Agreement.

5.10                     This
Agreement may not be assigned (except by operation of law) by any party without
the consent of the other parties.

5.11                     This
Agreement will be governed by and construed in accordance with the laws of the
State of Nevada applicable to contracts made and to be performed therein. 

5.12                    
The language used in this Agreement will be deemed to be the language chosen by
the parties to express their mutual intent, and no rule of strict construction
will be applied against any party. 

5.13                    
Delivery of an executed copy of this Agreement by electronic facsimile
transmission or other means of electronic communication capable of producing a
printed copy will be deemed to be execution and delivery of this Agreement as of
the date of its acceptance by the Company.

6

5.14                     The
schedules and exhibits are attached to this Agreement and incorporated
herein.

IN WITNESS WHEREOF, this Subscription Agreement is
executed as of the day and year first written above.

	Number of Shares Subscribed For: 	Shares 
	 	 
	Per Share Purchase Price: 	$0.75 per Share 
	 	 
	Aggregate Purchase Price: 	$ 
	 	 
	Signature of Subscriber or Authorized 
Signatory of
      Subscriber: 	
	 	 
	Name and Title of Authorized Signatory of 
Subscriber
      (if Subscriber is not an individual): 	
	 	 
	Name of Subscriber: 	 
    
	 	 
	Address of Subscriber: 	 
    
	 	 
	  	  
	 	 
	ACCEPTED BY: 	  
	 	 
	IMVISION THERAPEUTICS INC. 	  
	 	 
	Signature of Authorized Signatory: 	 
    
	 	 
	Name of Authorized Signatory: 	 
    
	 	 
	Position of Authorized Signatory: 	 
    
	 	 
	Date of Acceptance:Filed by Automated Filing Services Inc. (604) 609-0244 - ImVisioN Therapeutics Inc. - Exhibit 10.8

EXHIBIT 10.8 

Service Agreement 

between 

ImVisioN GmbH 
Feodor-Lynen-Strasse
5, D-30625 Hanover

- ImVisioN - 

and 

Digilab BioVisioN GmbH

Feodor-Lynen-Strasse 5, D-30625 Hanover 

- DBVN - 

Introduction 

ImVisioN runs its business on the
premises of the current main office of DBVN. In return for remuneration, DBVN
provides premises and staff infrastructure for this purpose within the framework
described in the following, and can provide further services on request.

In this connection, the parties agree
to the following: 

	1 	
      Subject of the agreement

	 	 	 
	1. 	
      In return for payment of the remuneration agreed upon in
      clause 6, DBVN is obligated to

	 	 	 
		a) 	
      supply premises (clause 2);

		b) 	
      supply personnel (clause 3);

		c) 	
      provide services within the area of IT (clause 4)
    and

		d) 	
      provide other services to be agreed upon at any time
      (clause 5).

	 	 	 
		
      The services mentioned in clauses 2-4 are described by
      the parties as „fixed services“, and the services mentioned in clause 5
      are called „variable services“.

	 	 	 
	2. 	
      The extent of the before-mentioned services covered by
      the remuneration appear in detail on the basis of monthly services from
      the quantity outline attached in

– App. 1 – 

		
      Services that go beyond this outline because of
      foundation or extent are subject to individual agreements. They are
      arranged through an offer from DBVN and an order from ImVisioN. The
      regulations of this service agreement also apply to these services, also
      when not men- tioned specifically.

	 	 
	3. 	
      If the amounts calculated for fixed services
      (clauses 2, 3 and 4) in the quantity outline should no longer be
      necessary to that extent in the duration of this agreement, adjustment of
      the quantity outline with up to +/- 50% is possible at one month’s notice
      from the announcement of the adjustment until it comes into force, yet not
      until three months after this agreement has come into force. More
      extensive changes require termination and renegotiation of the con-
      tract.

	 	 
	4. 	
      From the time that the adjustment comes into force, the
      remuneration according to the ad- justment of the quantity outline is to
      be paid.

	§ 2 	 Supply of premises 

	  	  
	  

	1. 	 At the main office of DBVN, DBVN
        supplies fully equipped offices and laboratories for Im- VisioN. This
        includes (listed in detail in ENCL. 1): 

	  	  
	  

	  	 - 
	 supply of premises, 

	  	 - 
	 supply of inventory, 

	  	 - 
	 supply of laboratory equipment, 

	  	 - 
	 supply of communication equipment (telephone,
        Internet, fax), 

		 - 
	 supply of IT hardware (PC, network, printer,
        etc.) incl. current Office software (how- ever, cf. section § 4),
      

	  	 - 
	 supply of materials for office use, 

	  	 - 
	 co-use of colour printers, copy machines,
        scanners, 

	  	 - 
	 co-use of seminar and meeting rooms as per
        agreement, 

	  	 - 
	 co-use of common rooms, 

	  	 - 
	 co-use of archive rooms. 

	  	  
	  

	2. 	 The supply includes technical
        equipment to the extent that it is used by DBVN. Equipment beyond this
        standard requires special agreement. Replacement of equipment only occurs
        in case of malfunction. 

	  	  
	  

	3. 	 If the laboratories used by ImVisioN
        are run as S1 laboratories, ImVisioN has the sole re- sponsibility
        for correct notification and regulatory operation of these laboratories.
      

	  	  
	  

	§ 3 	 Supply of secretary service
      

	  	  
	  

	1. 	 DBVN constantly supplies work
        capacity for secretary work from its own staff to the extent determined
        in the quantity outline 

	  	  
	  

	2. 	 The selection of employees for
        the above-mentioned services is subject to the assessment of DBVN. If
        DBVN does not have the appropriate staff capacity to the extent necessary,
        DBVN can terminate the agreement with regard to these services at one
        month’s notice. 

	  	  
	  

	§ 4 	 Services within the area of
        IT 

	  	  
	  

	1. 	 DBVN makes the software used by
        DBVN in the network used by DBVN available for ImVi- sioN. This mainly
        includes standard software in the area of office communication (MS-Office,
        etc.). Carrying out updates of this software is subject to the judgment
        of DBVN; therefore, ImVisioN is not entitled to specific software or a
        specific or new software version. 

	  	  
	  

	2. 	 Within the scope of its own business,
        DBVN maintains the functionality of the supplied soft- ware as well as
        possible. Any further work on the software requires previous acceptance
        from DBVN and is charged to ImVisioN. ImVisioN is not entitled to specific
        access to the soft- ware

	  	  
	  

	3. 	 The services include data security
        to the extent that DBVN carries out data security. 

	  	  
	  

	4. 	 The service also includes continuous
        maintenance of a web page for ImVisioN. This does not include any external
        costs connected with this. 

	  	  
	  

	§ 5 	 Variable services 

	  	  
	  

		 A pre-planning time of 4 weeks
        is agreed upon for the services listed below, in order for both parties
        to be able to adjust their work to the supply times agreed upon in the
        pre-planning: 

	  	  
	  

	  	 - 
	 Project management 

	  	 - 
	 HPLC service 

	  	 - 
	 Handling of patents 

	  	 - 
	 Expertise with regard to production
        and molecular biology 

		 The persons that are to provide
        the variable services may only be exchanged with the consent of both parties.
      

	  	  

       

	  	 Any entitlement to these services
        is subject to express confirmation from DBVN. 

	  	  

       

	§ 6 	 Remuneration 

	  	  

       

	1. 	 For fixed services, in
        accordance with clauses 2, 3 and 4, DBVN receives a standard amount of
        8,500 EUR (eight thousand five hundred) net to be paid every month in
        advance. These services do not result in a later document for receipt.
      

	  	  

       

	2. 	 For variable services,
        in accordance with clause 5, DBVN receives remuneration in accor- dance
        with the net hourly rates stated in APPENDIX 1. These services are paid
        on a monthly basis and are payable 10 days after invoicing. 

	  	  

       

	§ 7 	 Confidentiality 

	  	  

       

	1. 	 In the duration of this agreement
        and beyond the termination of the agreement, the parties are obligated
        to keep any technical information or business information that they have
        acquired before and during this agreement confidential, also when the
        information has not been specified as specifically secret or confidential.
      

	  	  

       

	2. 	 The parties to this agreement
        are also to make sure that confidential information is not passed on by
        any third party that works with or for the party in question. 

	  	  

       

	3. 	 If a party becomes aware that
        confidential documents, business or operational secrets are published
        through the know-how of a third party or if a third party fails to keep
        documents confidential, this party is to inform the other party about
        this without delay. 

	  	  

       

	4. 	 Punishable violation of the
        before-mentioned obligations of confidentiality results in a con- tractual
        penalty for the violating party of 15,000 Euro for each violation, from
        which any other contractual penalties under this agreement are not subtracted.
        Any further legal claims for damages are not affected by the contractual
        penalties. 

	  	  

       

	§ 8 	 Liability 

	  	  

       

		 The parties limit the liability
        under this agreement to matters caused by intentional or grossly negligent
        conduct. 

	  	  

       

	§ 9 	 Duration of the agreement
      

	  	  

       

	1. 	 This agreement comes into force
        with retrospective effect from the 1st of February 2006 and
        is terminable at 3 months’ notice to the end of a quarter. The costs
        mentioned in Appendix 1 for the second floor will not be charged until
        from the 1st of April 2006. 

	  	  

       

	2. 	 A party’s right to extraordinary
        termination for an important reason because of violation of the agreement
        or similar occurrences is not changed. More specifically, it is considered
        an important reason for termination of the contract when a party to this
        agreement intentionally or negligently causes harm and the results of
        this are not eliminated within 30 days on de- mand. 

	§ 10 	
      Other stipulations, choice of court and venue
    

	  	
      

	1. 	
      Apart from the arrangements stated in this agreement,
      there are no other arrangements be- tween the parties. Any further
      arrangements are hereby rendered irrelevant. Other arrange- ments,
      extensions and changes to this agreement only apply when in writing. This
      also applies to cancellation of this clause about the requirement of
      information in writing. 

	  	
      

	2. 	
      German legislation applies to all matters regarding this
      agreement. The venue of all disputes with regard to this agreement is
      Hanover. 

	  	
      

	§ 11 	
      Escape clause 

	  	
      

	1. 	
      If current or future stipulations in this contract are
      not legal or practicable or later lose their legality or practicability,
      totally or partly, the validity of the other stipulations in this agree-
      ment is not affected. This also applies if it turns out that the agreement
      contains deficiencies. 

	  	
      

	2. 	
      Instead of the ineffective or impracticable stipulation
      or for completion of the deficiency, a suitable arrangement should apply
      that the parties would have agreed upon if they had thought of the matter
      at the entering into the agreement. This also applies when the
      ineffectiveness af- fects the extent of a service or time limit stated in
      this agreement; in such cases, the agreed service or time limit is
      replaced by the closest possible legal extent of the service or time
      limit. 

	  	
      

	3. 	
      If the effect of a stipulation in accordance with the
      above can only be achieved through agreement on and with consideration for
      particular formal provisions, the parties will be obli- gated to carry out
      the required actions and give the necessary statements.

	 	Hannover, the 4/5/06	 	  
	 	 	 	 
	 	ImVisioN GmbH 	 	  
	 	 	 	 
	 	/s/ Martin Steiner 	 	/s/ Horst Rose 
	 	Geschäftsführer/CEO 	 	Geschäftsführer/COO 
	 	  	 	  
	 	Hannover, the 10/4/06	 	  
	 	 	 	 
	 	Digilab BioVisioN GmbH 	 	  
	 	 	 	 
	 	/s/ Wolfram Rodatz 	 	  
	 	Managing
      Director

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00111-of-00352.parquet"}]]